SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 13G/A

(Amendment No. 3)

 

Under the Securities Exchange Act of 1934

 

 

 

 

Threshold Pharmaceuticals, Inc.

(Name of Issuer)

 

 

COMMON STOCK

(Title of Class of Securities)

 

 

885807 10 7

(CUSIP Number)

 

 

December 31, 2008

(Date of Event Which Requires Filing of this Statement)

 

Check appropriate box to designate the rule pursuant to which this Schedule is filed:

[¨] Rule 13d-1(b)

[x] Rule 13d-1(c)

[¨] Rule 13d-1(d)

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(Continued on following pages)

 

Page 1 of 10 Pages


CUSIP No. 885807 10 7    13G   

 

 

  1  

NAME OF REPORTING PERSON

S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 

Three Arch Partners III, L.P. (“TAP III”)

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  x

(b)  ¨

   
  3  

SEC USE ONLY

 

   
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

   

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

 

  5    SOLE VOTING POWER

 

       2,060,624*

 

  6    SHARED VOTING POWER

 

       See response to row 5

 

  7    SOLE DISPOSITIVE POWER

 

       2,060,624*

 

  8    SHARED DISPOSITIVE POWER

 

       See response to row 7

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,060,624*

   
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

 

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

13.54%

   
12  

TYPE OF REPORTING PERSON

 

PN

   

 

* Includes a warrant to purchase 372,149 shares of common stock that is exercisable within 60 days of December 31, 2008

 

Page 2 of 10 pages


CUSIP No. 885807 10 7    13G   

 

 

  1  

NAME OF REPORTING PERSON

S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 

Three Arch Associates III, L.P. (“TAA III”)

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  x

(b)  ¨

   
  3  

SEC USE ONLY

 

   
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

   

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

 

  5    SOLE VOTING POWER

 

       110,777*

 

  6    SHARED VOTING POWER

 

       See response to row 5

 

  7    SOLE DISPOSITIVE POWER

 

       110,777*

 

  8    SHARED DISPOSITIVE POWER

 

       See response to row 7

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

110,777*

   
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

 

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

0.73%

   
12  

TYPE OF REPORTING PERSON

 

PN

   

 

* Includes a warrant to purchase 20,007 shares of common stock that is exercisable within 60 days of December 31, 2008

 

Page 3 of 10 pages


CUSIP No. 885807 10 7    13G   

 

  1  

NAME OF REPORTING PERSON

S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 

Three Arch Management III, L.L.C. (“TAM III”)

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  x

(b)  ¨

   
  3  

SEC USE ONLY

 

   
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Delaware

   

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

 

  5    SOLE VOTING POWER

 

       2,171,401*

 

  6    SHARED VOTING POWER

 

       See response to row 5

 

  7    SOLE DISPOSITIVE POWER

 

       2,171,401*

 

  8    SHARED DISPOSITIVE POWER

 

       See response to row 7

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,171,401*

   
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

 

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

14.27%

   
12  

TYPE OF REPORTING PERSON

 

OO

   

 

* Includes warrants to purchase 392,156 shares of common stock that are exercisable within 60 days of December 31, 2008.

 

Page 4 of 10 pages


CUSIP No. 885807 10 7    13G   

 

  1  

NAME OF REPORTING PERSON

S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 

Mark A. Wan

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  x

(b)  ¨

   
  3  

SEC USE ONLY

 

   
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

USA

   

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

 

  5    SOLE VOTING POWER

 

       0

 

  6    SHARED VOTING POWER

 

       2,171,401*

 

  7    SOLE DISPOSITIVE POWER

 

       0

 

  8    SHARED DISPOSITIVE POWER

 

       2,171,401*

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,171,401*

   
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

 

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

14.27%

   
12  

TYPE OF REPORTING PERSON

 

IN

   

 

* Includes warrants to purchase 392,156 shares of common stock that are exercisable within 60 days of December 31, 2008.

 

Page 5 of 10 pages


CUSIP No. 885807 10 7    13G   

 

 

  1  

NAME OF REPORTING PERSON

S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 

Wilfred E. Jaeger

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  x

(b)  ¨

   
  3  

SEC USE ONLY

 

   
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Canada

   

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

 

  5    SOLE VOTING POWER

 

       9,375 *

 

  6    SHARED VOTING POWER

 

       2,171,401**

 

  7    SOLE DISPOSITIVE POWER

 

       9,375 *

 

  8    SHARED DISPOSITIVE POWER

 

       2,171,401**

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,180,776**

   
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

 

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

14.33%

   
12  

TYPE OF REPORTING PERSON

 

IN

   

 

* Includes 9,375 shares of common stock subject to options exercisable within 60 days of December 31, 2008.

 

** Includes warrants to purchase 392,156 shares of common stock that are exercisable within 60 days of December 31, 2008.

 

Page 6 of 10 pages


CUSIP No. 885807 10 7    13G   

 

 

  1  

NAME OF REPORTING PERSON

S.S OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

 

Barclay Nicholson

   
  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a)  x

(b)  ¨

   
  3  

SEC USE ONLY

 

   
  4  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

USA

   

 

NUMBER OF  

SHARES  

BENEFICIALLY  

OWNED BY  

EACH  

REPORTING  

PERSON  

WITH  

 

 

  5    SOLE VOTING POWER

 

       0

 

  6    SHARED VOTING POWER

 

       2,171,401*

 

  7    SOLE DISPOSITIVE POWER

 

       0

 

  8    SHARED DISPOSITIVE POWER

 

       2,171,401*

  9  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,171,401*

   
10  

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

 

¨

 

11  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

14.27%

   
12  

TYPE OF REPORTING PERSON

 

IN

   

 

** Includes warrants to purchase 392,156 shares of common stock that are exercisable within 60 days of December 31, 2008.

 

Page 7 of 10 pages


CUSIP No. 885807 10 7    13G   

 

 

Item 1.

 

  (a) Name of Issuer:

Threshold Pharmaceuticals, Inc. (the “Issuer”)

 

  (b) Address of Issuer’s Principal Executive Offices:

1300 Seaport Boulevard, Redwood City, CA 94063

 

Item 2.

 

  (a) Name of Person Filing:

Three Arch Partners III, L.P. (“TAP III”), Three Arch Associates III, L.P. (“TAA III”), Three Arch Management III, L.L.C. (“TAM III”), Mark A. Wan (“Wan”), Wilfred E. Jaeger (“Jaeger”), and Barclay Nicholson (“Nicholson”). The foregoing entities and individuals are collectively referred to as the “Reporting Persons.” Wan, Jaeger, and Nicholson are the sole managing members of TAM III, the sole general partner of TAP III and TAA III and may be deemed to have sole power to vote the shares reported. TAA III invests alongside TAP III in all investments made by TAP III.

 

  (b) Address of Principal Business Office:

3200 Alpine Road, Portola Valley, CA 94028

 

  (c) Citizenship:

See Row 4 of each cover page

 

  (d) Title of Class of Securities:

Common Stock, $0.001 par value per share

 

  (e) CUSIP Number:

885897 10 7

 

Item 3. If this statement is filed pursuant to Rules 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.

 

Item 4. Ownership

The following information with respect to the ownership of the Common Stock of the Issuer by the person filing this statement is provided as of December 31, 2008:

 

  (a) Amount Beneficially Owned:

See Row 9 of each cover page

 

  (b) Percent of Class:

See Row 11 of each cover page. The approximate percentages of common stock reported as beneficially owned by the Reporting Persons is based on 15,214,044 shares of common stock outstanding as of October 31, 2008 as reported in the Issuer’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2008.

 

Page 8 of 10 pages


CUSIP No. 885807 10 7    13G   

 

 

  (c) Number of shares as to which such person has:

 

  (i) sole power to vote or to direct the vote:

See Row 5 of each cover page

 

  (ii) shared power to vote or to direct the vote:

See Row 6 of each cover page

 

  (iii) sole power to dispose or to direct the disposition of:

See Row 7 of each cover page

 

  (iv) shared power to dispose or to direct the disposition of:

See Row 8 of each cover page

 

Item 5. Ownership of Five Percent or Less of a Class

Not applicable.

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person

Under certain circumstances set forth in the limited partnership agreements of TAP III and TAA III and the limited liability company agreement of TAM III, the general and limited partners of each such entity may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the issuer owned by each such entity of which they are a partner.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not applicable.

 

Item 8. Identification and Classification of Members of the Group

Not applicable.

 

Item 9. Notice of Dissolution of the Group

Not applicable.

 

Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

Page 9 of 10 pages


CUSIP No. 885807 10 7    13G   

 

SIGNATURE

After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

 

Date: January 29, 2009
THREE ARCH PARTNERS III, L.P.
By:   Three Arch Management III, L.L.C.
By:   /s/ Barclay Nicholson
  Barclay Nicholson
  Managing Member
THREE ARCH ASSOCIATES III, L.P.
By:   Three Arch Management III, L.L.C.
By:   /s/ Barclay Nicholson
  Barclay Nicholson
  Managing Member
THREE ARCH MANAGEMENT III, L.L.C.
By:   /s/ Barclay Nicholson
  Barclay Nicholson
  Managing Member
MARK A. WAN
By:   /s/ Barclay Nicholson
  Barclay Nicholson
  Authorized Signature
WILFRED E. JAEGER
By:   /s/ Barclay Nicholson
  Barclay Nicholson
  Authorized Signature
BARCLAY NICHOLSON
By:   /s/ Barclay Nicholson
  Barclay Nicholson

This Schedule 13G was executed pursuant to a Statement Appointing Designated Filer and Authorized Signatories. Note that copies of the applicable Statement Appointing Designated Filer and Authorized Signatories are already on file with the appropriate agencies.

 

Page 10 of 10 pages